References
- Zarate C A, Tohen M, Banov M D, et al. Is clozapine a mood stabiliser?. J Clin Psychiatry 1995; 56: 108–12
- ‘Zyprexa’, Lilly Industries Limited, Basingstoke, Hants. Summary of Product Characteristics. 1996
- Williamson D J, Beasley C M, Iran P V, et al. Olanzapine versus haloperidol: results of the multicenter international trial. Eur Psychiatry 1996; 11: 202–3
- Iran P V, Dellva M A, Tollefson G D, et al. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia. J Clin Psychiatry 1997; 58: 205–11
- Taylor D. Monitoring the new atypical antipsychotic drugs. Prog Neural Psychiatry 1997; 1: 13–15
- Barnes T RE, Kane J M. Choosing between old and new antipsychotics. Curr Opin Psychiatry 1996; 9: 41–4
- Carpenter W T, Conley R R, Buchanan R W, et al. Patient response and resource management: another view of clozapine treatment of schizophrenia. Am J Psychiatry 1995; 152: 827–32
- Meltzer H Y. Editorial: Clozapine: is another view valid?. Am J Psychiatry 1995; 152: 821–5